Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.14
- The company has reported losses. Due to this company has reported negative ROCE
Negative results in Mar 26
Stock is technically in a Bearish range
Risky - Negative EBITDA
Stock DNA
Trading & Distributors
INR 11 Cr (Micro Cap)
17.00
19
0.00%
0.14
5.66%
0.28
Total Returns (Price + Dividend) 
Suncare Traders for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Are Suncare Traders Ltd latest results good or bad?
Suncare Traders Ltd's latest financial results reflect a challenging operational environment characterized by significant volatility and fundamental weaknesses. In the most recent quarter ending December 2025, the company reported net sales of ₹0.00 crores, indicating no year-over-year growth compared to the previous year, which also faced a drastic decline. This stagnation in revenue highlights the company's struggle to establish a consistent operational momentum. The standalone net profit for the same period was ₹0.28 crores, which represents a decline of 63.16% year-over-year. This sharp decrease in profitability raises concerns about the sustainability of the company's earnings, especially as the operating profit margin excluding other income remained at 0.00%, suggesting that core business operations are not generating positive cash flows. Overall, Suncare Traders Ltd's financial trajectory continues...
Read MoreWhen is the next results date for Suncare Traders Ltd?
The next results date for Suncare Traders Ltd is scheduled for 07 May 2026....
Read More
Suncare Traders Ltd Falls to 52-Week Low of Rs 0.5 as Sell-Off Deepens
A sharp decline of 45.36% over the past year has culminated in Suncare Traders Ltd hitting a fresh 52-week low of Rs 0.5 on 22 Apr 2026, underscoring persistent weakness despite a broader market that has shown resilience in recent weeks.
Read More Announcements 
Closure of Trading Window
11-Jun-2026 | Source : BSEPFA
Compliances-Reg.24(A)-Annual Secretarial Compliance
21-May-2026 | Source : BSEPFA
Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2026 And Outcome Of The Board Meeting Held On Thursday 7Th May 2026.
07-May-2026 | Source : BSEThis is to inform you that Outcome of the Board Meeting of the Company held on today i.e. Thursday 7th May 2026 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations 2015 has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March 2026. 2.) Independent Auditors Report in pursuance with Regulation 33 of SEBI (LODR) Regulations 2015 for the F.Y. 31st March 2026. Further we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 for the financial year ended on March 31 2026 with Unmodified Opinion. The board meeting commenced at 05.10 PM and concluded at 05:40 PM. We request you to kindly take on record the same. Thanking You.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Suncare Traders Ltd has announced 2:10 stock split, ex-date: 06 Mar 20
Suncare Traders Ltd has announced 2:1 bonus issue, ex-date: 06 Mar 20
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Biogen Pharmachem Industries Limited (4.29%)
Nilmesh Infrabuild Llp (11.78%)
66.02%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -560.00% vs -121.05% in Mar 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -633.33% vs 108.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -84.81% vs 241.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
YoY Growth in year ended Mar 2026 is 11.86% vs 51.28% in Mar 2025